Selection and characterization of human anti-mage-a1 scFv and immunotoxin

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 8, 2013, Pages 1259-1266

  Lin, Hong ^a   Mao, Yuan ^b   Zhang, Da Wei ^c   Li, Hu ^d   Qiu, Jin Rong ^d   Zhu, Jin ^d,e   Chen, Ren Jie ^c  

^a Jiangsu Province Blood Center   (China)

^b Jiangsu Province Official Hospital   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e Huadong Medical Institute of Biotechniques   (China)

Author keywords

Anti mage a1 scFv fragment; Immunotoxin; Phage display antibody library

Indexed keywords

IMMUNOTOXIN; MELANOMA ANTIGEN 1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIBODY LIBRARY; ANTIBODY PRODUCTION; ANTIGEN PURIFICATION; APOPTOSIS; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOPRECIPITATION; IMMUNOTOXICITY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ABRIN; AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; HUMANS; IMMUNOTOXINS; MELANOMA-SPECIFIC ANTIGENS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS; SINGLE-CHAIN ANTIBODIES;

EID: 84888233757     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113139990134     Document Type: Article

References (23)

1. Demarest, S.J., Hariharan, K.; Dong, J. Emerging antibody combinations in oncology. MAbs, 2011, 3, 338-351.
2. Goldenberg, D.M.; Sharkey, R.M. Using antibodies to target cancer therapeutics. Expert. Opin. Biol. Ther., 2012, 12, 1173-1190.
3. Cao, Y.; Marks, J.D.; Huang, Q.; Rudnick, S.I.; Xiong, C.; Hittelman, W.N.; Wen, X.; Marks, J.W.; Cheung, L.H.; Boland, K.; Li, C.; Adams, G.P.; Rosenblum, M.G. Single-chain antibodybased immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity. Mol. Cancer. Ther., 2012, 11, 143-153.
4. Ogata, K.; Aihara, R.; Mochiki, E.; Ogawa, A.; Yanai, M.; Toyomasu, Y.; Ando, H.; Ohno, T.; Asao, T.; Kuwano, H. Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer. Ann. Surg. Oncol., 2011, 18, 1195-1203.
5. Ries, J.; Schultze-Mosgau, S.; Neukam, F.; Diebel, E.; Wiltfang, J. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int. J. Oncol., 2005, 26, 817-824.
6. Shin, K.C.; Choi, E.Y.; Chung, J.H.; Jeon, C.; Lee, K.H. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy. Anticancer. Res., 2012, 32, 163-167.
7. Bao, L.; Dunham, K.; Lucas, K. MAGE-A1, MAGE-A3, and NYESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing. Cancer. Immunol. Immunother., 2011, 60, 1299-1307.
8. Weisser, N.E.; Hall, J.C. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics. Biotechnol. Adv., 2009, 27, 502-520.
9. Carter, P. Improving the efficacy of antibody-based cancer therapies. Nat. Rev. Cancer., 2001, 1, 118-129.
10. Robinson, M.K.; Hodge, K.M.; Horak, E.; Sundberg, A.L.; Russeva, M.; Shaller, C.C.; von Mehren, M.; Shchaveleva, I.; Simmons, H.H.; Marks, J.D.; Adams, G.P. Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro. Br. J. Cancer., 2008, 99, 1415-1425.
11. Yang, J.; Chen, R.; Wei, J.; Zhang, F.; Zhang, Y.; Jia, L.; Yan, Y.; Luo, W.; Cao, Y.; Yao, L.; Sun, J.; Xu, Z.; Yang, A. Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein. Appl. Microbiol. Biotechnol., 2010, 86, 1067-1075.
12. Thie, H.; Meyer, T.; Schirrmann, T.; Hust, M.; Dübel, S. Phage display derived therapeutic antibodies. Curr. Pharm. Biotechnol., 2008, 9, 439-446.
13. Erdag, B.; Balcioglu, B.K.; Bahadir, A.O.; Serhatli, M.; Kacar, O.; Bahar, A.; Seker, U.O.; Akgun, E.; Ozkan, A.; Kilic, T.; Tamerler, C.; Baysal, K. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2. Biotechnol. Appl. Biochem., 2011, 58, 412-422.
14. Andris-Widhopf, J.; Steinberger, P.; Fuller, R.; Rader, C.; Barbas, C.F. III. Generation of human scFv antibody libraries: PCR amplification and assembly of light and heavy-chain coding sequences, Cold Spring Harb Protoc, 2011.
15. Barbas, C.F. III.; Burton, D.R.; Scott, J.; Silverman, G. Eds. Phage Display of Proteins and Peptides: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 2000.
16. Beatty, J.D.; Beatty, B.G.; Vlahos, W.G. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J. Immunol. Methods., 1987, 100, 173-179.
17. Smith, P.K.; Krohn, R.I.; Hermanson, G.T.; Mallia, A.K.; Gartner, F.H.; Provenzano, M.D.; Fujimoto, E.K.; Goeke, N.M.; Olson, B.J.; Klenk, D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem., 1985, 150, 76-85.
18. Mao, Y.; Zhang, D.W.; Wen, J.; Cao, Q.; Chen, R.J.; Zhu, J.; Feng, Z.Q. A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor. Int. J. Mol. Sci., 2012, 13, 2208-2218.
19. Mao, Y.; Zhang, D.W.; Zhu, H.; Lin, H.; Xiong, L.; Cao, Q.; Liu, Y.; Li, Q.D.; Xu, J.R.; Xu, L.F.; Chen, R.J. LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL). Diagn. Pathol., 2012, 7, 178. doi: 10.1186/1746-1596-7-178. [Epub ahead of print]
20. Mao, Y.; Zhang, D.W.; Lin, H.; Xiong, L.; Liu, Y.; Li, Q.D.; Ma, J.; Cao, Q.; Chen, R.J.; Zhu, J.; Feng, Z.Q. Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma. J. Exp. Clin. Cancer. Res., 2012, 31, 101. doi: 10.1186/1756-9966-31-101. [Epub ahead of print]
21. Chen, R.; Zhang, D.; Mao, Y.; Zhu, J.; Ming, H.; Wen, J.; Ma, J.; Cao, Q.; Lin, H.; Tang, Q.; Liang, J.; Feng, Z. A human Fabbased immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo. Mol. Cancer. Ther., 2012, 11, 594-603.
22. Bebb, G.; Smith, C.; Rorke, S.; Boland, W.; Nicacio, L.; Sukhoo, R.; Brade, A. Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy. Cancer. Chemother. Pharmacol., 2011, 67, 837-845.
23. Kato, J.; Satake, N.; O'Donnell, R.T.; Abuhay, M.; Lewis, C.; Tuscano, J.M. Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia. Leuk. Res., 2012. doi: 10.1016/ j.leukres.2012.09.010. [Epub ahead of print].